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X-linked ichthyosis is an inherited disorder due to
steroid sulfatase de®ciency. It is clinically character-
ized by dark, adhesive, and regular scales of the skin.
Most X-linked ichthyosis patients present large dele-
tions of the STS gene and ¯anking markers; a min-
ority show a point mutation or partial deletion of the
STS gene. In this study we analyzed the STS gene in
a family with simultaneous occurrence of X-linked
ichthyosis and ichthyosis vulgaris. X-linked ichthyo-
sis diagnosis was con®rmed through steroid sulfatase
assay in leukocytes using 7-[3H]-dehydroepiandros-
terone sulfate as a substrate. Exons 1, 2, 5, and 6±10,
and the 5¢ ¯anking markers DXS1130, DXS1139, and
DXS996 of the STS gene were analyzed by polymer-
ase chain reaction. X-linked ichthyosis patients of
the family (n = 4 males) had undetectable levels of
STS activity (0.00 pmol per mg protein per h). The
DNA analysis showed that only exons 6±10 and the
5¢ ¯anking markers of the STS gene were present.
We report the ®rst partial deletion of the STS gene
spanning exons 1±5 in X-linked ichthyosis patients.
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S
teroid sulfatase (STS, EC 3.1.6.2) is a microsomal
enzyme that is capable of hydrolyzing 3-b-hydroxy-
steroid sulfates (Hobkirk, 1985). It shows an ubiquitous
distribution in human tissues (Dibbelt and Kuss, 1991).
STS de®ciency results in X-linked ichthyosis (XLI), an
inherited disorder characterized by dark, adhesive, and regular
scales of the skin (Shapiro and Weiss, 1978). XLI patients have
increased levels of cholesterol sulfate in the stratum corneum,
which appears to be responsible for the scaly skin (Williams and
Elias, 1981). Cholesterol sulfate produces a barrier abnormality in
intact skin and extracellular anomalies in isolated stratum corneum
(Zettersten et al, 1998), and inhibits formation of detergent-
insoluble membrane domains (Xu and London, 2000). Cholesterol
sulfate also acts as a transcriptional factor of the transglutaminase 1
gene in human keratinocytes (Kawabe et al, 1998). It has been
proposed that epidermal changes in XLI could be a consequence of
transglutaminase 1 dysfunction due to the accumulation of
cholesterol sulfate (Nemes et al, 2000).
The STS gene is located on the short arm of the X-chromosome
(Muller et al, 1981). Most XLI patients present large deletions of the
entire STS gene and ¯anking sequences (Bonifas et al, 1987;
Shapiro et al, 1989; Cuevas et al, 1997; Aviram et al, 2000), but a
few point mutations and six partial deletions have also been
reported (Bonifas et al, 1987; Ballabio et al, 1989; Shapiro et al,
1989; Basler et al, 1992; Nomura et al, 1995; Alperin and Shapiro,
1997; Morita et al, 1997; Aviram et al, 2000; Oyama et al, 2000;
Sugawara et al, 2000; Valdes et al, 2000). A 3 bp of homology and
an incorporation of 8 bp were found at the site of the deletion
junction in two unrelated cases (Bernatowicz et al, 1992; Yen et al,
1994). We previously reported a family with the simultaneous
occurrence of XLI and ichthyosis vulgaris (Cuevas et al, 1999) and
in this study we analyzed the STS gene in this family.
MATERIALS AND METHODS
Patients The XLI patients of the family were referred to the Genetic
Department of the General Hospital of Mexico. They were informed about
the characteristics of the study and they agreed to participate. The protocol
was accepted by the Ethics Committee of the General Hospital. Physical
examination of the XLI patients (n = 4 males) showed a moderate degree of
ichthyosis on the trunk, back, and extremities. Two of them had also
cryptorchidism corrected surgically. No other clinical ®ndings were
observed.
STS assay STS activity was determined in leukocytes of the XLI patients
as follows: 10 ml of blood was obtained with a heparinized syringe. The
leukocyte pellet was obtained through centrifugation and washed three
times with 0.9% NaCl. STS assay was performed in the leukocyte pellet,
which was homogenized in chilled 0.014 M Tris (hydroxymethyl)-
aminomethane buffer with a polytron in two cycles of 20 s and 10 s,
respectively. 7-[3H]-dehydroepiandrosterone sulfate (16.3 Ci per mmol,
NEN, Boston, MA) was used as the enzyme substrate. Assay conditions
were pH 7.0 at 37°C for 1 h. The product of hydrolysis was recovered with
benzene (Merck, Germany, analytical grade) and read in a scintillation
spectrometer (Cuevas et al, 1993.). Each assay was performed twice.
Mutation detection DNA extraction was performed in the
conventional way (Lench et al, 1998). The STS gene was analyzed by
polymerase chain reaction (PCR). The conditions and primers to amplify
exons 1, 2, 5, and 6±10, and contiguous 5¢ ¯anking sequences DXS1130,
DXS1139, and DXS996 of the STS gene are shown in Table I (Ballabio
et al, 1990a; Schaefer et al, 1993; Valdes et al, 2000).
RESULTS AND DISCUSSION
The XLI patients of the family were shown to have undetectable
levels of STS activity (0.00 pmol per mg protein per h),
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corroborating the XLI diagnosis. DNA analysis showed a normal
ampli®cation of exons 6±10 and contiguous 5¢ ¯anking sequences
DXS1130, DXS1139, and DXS996 of the STS gene (Figs 1 and 2).
PCR ampli®cation of exons 1, 2, and 5 failed to amplify these
regions. PCR was repeated three times for all segments and
identical results were obtained in each assay. These results indicated
that the STS gene in our family had a partial deletion, including
exons 1±5.
About 90% of STS de®ciency patients have large deletions of the
STS gene and ¯anking sequences. The presence of low copy
number repeats on either side of the STS gene, promoting unequal
crossing over, seems to play a part in the high frequency of these
interstitial deletions (Ballabio et al, 1990b; Yen et al, 1990).
Nevertheless, this mechanism does not apply to all STS gene
deletions as in our family, the deletion involved exons 1±5 of the
STS gene. DNA ampli®cation of exons 6±10 and 5¢ ¯anking
markers indicated that the deletion breakpoints thus lay within
intron 5 and between 5¢ ¯anking sequence DXS1130 and exon 1 of
the gene. Six unrelated patients with partial deletions of the STS
gene have been reported: (i) one patient had a deletion that started
within intron 7 and spanned exons 8±10 (Ballabio et al, 1989); (ii)
the second had a deletion which included exon 10 (Nomura et al,
1995); (iii) the third showed an intragenic deletion spanning exons
2±5 (Shapiro et al, 1989); (iv) the fourth had a deletion involving
exons 2±10 and 3¢ ¯anking sequences DXS1131 and DXS1133
(Valdes et al, 2000); and (v) the ®fth and sixth showed a partial
deletion at the 5¢ end of the STS gene (Aviram et al, 2000). Most of
these deletions causing XLI are located at the 3¢ end of the STS
gene, but in our family the partial deletion was present at the 5¢ end
of the gene. In two previous reports and in our family, there are
two intron regions in common in which the deletion breakpoints
occur. These regions comprise introns 1 and 5 of the STS gene. In
one case the deletion breakpoints lay within introns 1 and 5
(Shapiro et al, 1989), in the second one of the deletion breakpoints
was located within intron 1 (Valdes et al, 2000), and in our family
one of the deletion breakpoints lay within intron 5. Further studies
could provide evidence of some speci®c changes occurring in these
intron regions.
On the other hand, this partial deletion of the STS gene spanning
exons 1±5 also indicates the importance of the amino region of the
enzyme, a region that seems to be important for STS activity. In
conclusion, we report the ®rst partial deletion of the STS gene
extending over exons 1±5 in XLI.
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